Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14481 | 767 | 44.7 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
478 | 3 | PHAGE DISPLAY//CELL FREE PROTEIN SYNTHESIS//ANTIBODY ENGINEERING | 23687 |
1834 | 2 | PHAGE DISPLAY//ANTIBODY ENGINEERING//BISPECIFIC ANTIBODY | 6173 |
14481 | 1 | NANOBODY//SINGLE DOMAIN ANTIBODY//VHH | 767 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NANOBODY | authKW | 3464408 | 20% | 58% | 151 |
2 | SINGLE DOMAIN ANTIBODY | authKW | 2831293 | 14% | 66% | 108 |
3 | VHH | authKW | 1937575 | 10% | 62% | 78 |
4 | HEAVY CHAIN ANTIBODY | authKW | 1365714 | 5% | 84% | 41 |
5 | CHRISTIAN DOPPLER ANTIBODY ENGN | address | 337207 | 2% | 71% | 12 |
6 | IGNAR | authKW | 337207 | 2% | 71% | 12 |
7 | CAMELID ANTIBODIES | authKW | 284352 | 1% | 71% | 10 |
8 | NEW ANTIGEN RECEPTOR | authKW | 278670 | 1% | 100% | 7 |
9 | SINGLE DOMAIN ANTIBODY FRAGMENT | authKW | 268713 | 1% | 75% | 9 |
10 | CELLULAIRE MOL IMMUNOL | address | 231618 | 1% | 73% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 1733 | 41% | 0% | 313 |
2 | Biotechnology & Applied Microbiology | 1706 | 21% | 0% | 160 |
3 | Biochemical Research Methods | 916 | 12% | 0% | 94 |
4 | Immunology | 837 | 17% | 0% | 132 |
5 | Biophysics | 316 | 8% | 0% | 64 |
6 | Chemistry, Analytical | 129 | 7% | 0% | 54 |
7 | Veterinary Sciences | 106 | 5% | 0% | 40 |
8 | Medicine, Research & Experimental | 84 | 5% | 0% | 39 |
9 | Radiology, Nuclear Medicine & Medical Imaging | 46 | 4% | 0% | 33 |
10 | Cell Biology | 44 | 6% | 0% | 46 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHRISTIAN DOPPLER ANTIBODY ENGN | 337207 | 2% | 71% | 12 |
2 | CELLULAIRE MOL IMMUNOL | 231618 | 1% | 73% | 8 |
3 | VIVO CELLULAR MOL IMAGING | 146974 | 2% | 31% | 12 |
4 | MOL CELLULAR INTERACT | 142083 | 4% | 11% | 33 |
5 | CELLULAR MOL IMMUNOL | 125835 | 7% | 6% | 57 |
6 | CELLULAR MOL INTERACT | 117074 | 1% | 29% | 10 |
7 | GDR2352 | 106157 | 1% | 67% | 4 |
8 | GRP CELLULAR MOL IMMUNOL | 90991 | 1% | 57% | 4 |
9 | UNIT CELLULAR MOL IMMUNOL | 87138 | 1% | 24% | 9 |
10 | IN VIVO CELLULAR MOL IMAGING | 82669 | 1% | 23% | 9 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROTEIN ENGINEERING DESIGN & SELECTION | 30014 | 4% | 3% | 28 |
2 | MABS | 4364 | 1% | 1% | 9 |
3 | MOLECULAR IMMUNOLOGY | 3504 | 3% | 0% | 25 |
4 | JOURNAL OF CAMEL PRACTICE AND RESEARCH | 2799 | 1% | 1% | 8 |
5 | JOURNAL OF IMMUNOLOGICAL METHODS | 1965 | 3% | 0% | 22 |
6 | PORTLAND PRESS PROCEEDINGS | 1655 | 0% | 2% | 2 |
7 | BMC BIOTECHNOLOGY | 1651 | 1% | 1% | 7 |
8 | MOLECULAR IMAGING AND BIOLOGY | 1481 | 1% | 1% | 6 |
9 | HYBRIDOMA AND HYBRIDOMICS | 1456 | 0% | 1% | 3 |
10 | MICROBIAL CELL FACTORIES | 1431 | 1% | 1% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NANOBODY | 3464408 | 20% | 58% | 151 | Search NANOBODY | Search NANOBODY |
2 | SINGLE DOMAIN ANTIBODY | 2831293 | 14% | 66% | 108 | Search SINGLE+DOMAIN+ANTIBODY | Search SINGLE+DOMAIN+ANTIBODY |
3 | VHH | 1937575 | 10% | 62% | 78 | Search VHH | Search VHH |
4 | HEAVY CHAIN ANTIBODY | 1365714 | 5% | 84% | 41 | Search HEAVY+CHAIN+ANTIBODY | Search HEAVY+CHAIN+ANTIBODY |
5 | IGNAR | 337207 | 2% | 71% | 12 | Search IGNAR | Search IGNAR |
6 | CAMELID ANTIBODIES | 284352 | 1% | 71% | 10 | Search CAMELID+ANTIBODIES | Search CAMELID+ANTIBODIES |
7 | NEW ANTIGEN RECEPTOR | 278670 | 1% | 100% | 7 | Search NEW+ANTIGEN+RECEPTOR | Search NEW+ANTIGEN+RECEPTOR |
8 | SINGLE DOMAIN ANTIBODY FRAGMENT | 268713 | 1% | 75% | 9 | Search SINGLE+DOMAIN+ANTIBODY+FRAGMENT | Search SINGLE+DOMAIN+ANTIBODY+FRAGMENT |
9 | V H | 184909 | 2% | 39% | 12 | Search V+H | Search V+H |
10 | FCAB | 159240 | 1% | 100% | 4 | Search FCAB | Search FCAB |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MUYLDERMANS, S , (2013) NANOBODIES: NATURAL SINGLE-DOMAIN ANTIBODIES.ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82. VOL. 82. ISSUE . P. 775-797 | 105 | 71% | 222 |
2 | ROMAO, E , MORALES-YANEZ, F , HU, YZ , CRAUWELS, M , DE PAUW, P , HASSANZADEH, GG , DEVOOGDT, N , ACKAERT, C , VINCKE, C , MUYLDERMANS, S , (2016) IDENTIFICATION OF USEFUL NANOBODIES BY PHAGE DISPLAY OF IMMUNE SINGLE DOMAIN LIBRARIES DERIVED FROM CAMELID HEAVY CHAIN ANTIBODIES.CURRENT PHARMACEUTICAL DESIGN. VOL. 22. ISSUE 43. P. 6500 -6518 | 183 | 62% | 1 |
3 | STEELAND, S , VANDENBROUCKE, RE , LIBERT, C , (2016) NANOBODIES AS THERAPEUTICS: BIG OPPORTUNITIES FOR SMALL ANTIBODIES.DRUG DISCOVERY TODAY. VOL. 21. ISSUE 7. P. 1076 -1113 | 146 | 48% | 3 |
4 | EYER, L , HRUSKA, K , (2012) SINGLE-DOMAIN ANTIBODY FRAGMENTS DERIVED FROM HEAVY-CHAIN ANTIBODIES: A REVIEW.VETERINARNI MEDICINA. VOL. 57. ISSUE 9. P. 439 -513 | 109 | 78% | 20 |
5 | RAHBARIZADEH, F , AHMADVAND, D , SHARIFZADEH, Z , (2011) NANOBODY; AN OLD CONCEPT AND NEW VEHICLE FOR IMMUNOTARGETING.IMMUNOLOGICAL INVESTIGATIONS. VOL. 40. ISSUE 3. P. 299 -338 | 128 | 61% | 31 |
6 | VAN BOCKSTAELE, F , HOLZ, JB , REVETS, H , (2009) THE DEVELOPMENT OF NANOBODIES FOR THERAPEUTIC APPLICATIONS.CURRENT OPINION IN INVESTIGATIONAL DRUGS. VOL. 10. ISSUE 11. P. 1212 -1224 | 99 | 76% | 72 |
7 | DE MARCO, A , (2011) BIOTECHNOLOGICAL APPLICATIONS OF RECOMBINANT SINGLE-DOMAIN ANTIBODY FRAGMENTS.MICROBIAL CELL FACTORIES. VOL. 10. ISSUE . P. - | 110 | 60% | 49 |
8 | DE MEYER, T , MUYLDERMANS, S , DEPICKER, A , (2014) NANOBODY-BASED PRODUCTS AS RESEARCH AND DIAGNOSTIC TOOLS.TRENDS IN BIOTECHNOLOGY. VOL. 32. ISSUE 5. P. 263-270 | 59 | 72% | 63 |
9 | WANG, YZ , FAN, Z , SHAO, L , KONG, XW , HOU, XJ , TIAN, DR , SUN, Y , XIAO, YZ , YU, L , (2016) NANOBODY-DERIVED NANOBIOTECHNOLOGY TOOL KITS FOR DIVERSE BIOMEDICAL AND BIOTECHNOLOGY APPLICATIONS.INTERNATIONAL JOURNAL OF NANOMEDICINE. VOL. 11. ISSUE . P. 3287 -3302 | 75 | 72% | 1 |
10 | HARMSEN, MM , DE HAARD, HJ , (2007) PROPERTIES, PRODUCTION, AND APPLICATIONS OF CAMELID SINGLE-DOMAIN ANTIBODY FRAGMENTS.APPLIED MICROBIOLOGY AND BIOTECHNOLOGY. VOL. 77. ISSUE 1. P. 13 -22 | 65 | 76% | 252 |
Classes with closest relation at Level 1 |